87
Views
9
CrossRef citations to date
0
Altmetric
Anticancer Chemotherapy

Protective Effect of Leuprolide on Ovarian Function in Young Women Treated with Adjuvant Chemotherapy for Early Breast Cancer: A Multicenter Phase II Study

Pages 740-743 | Published online: 18 Jul 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Yan-Wei Shen, Xiao-Man Zhang, Meng Lv, Ling Chen, Tian-Jie Qin, Fan Wang, Jiao Yang, Pei-Jun Liu & Jin Yang. (2015) Utility of gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage in premenopausal women with breast cancer: a systematic review and meta-analysis. OncoTargets and Therapy 8, pages 3349-3359.
Read now

Articles from other publishers (8)

Rhiannon White, Anna Wilson, Natasha Bechman, Stephen D. Keay, Lucy McAvan, Siobhan Quenby & Joshua Odendaal. (2023) Fertility preservation, its effectiveness and its impact on disease status in pre-menopausal women with breast cancer: A systematic review and meta-analysis. European Journal of Obstetrics & Gynecology and Reproductive Biology 287, pages 8-19.
Crossref
Sung Eun Kim, Won-Ji Kim, DooSeok Choi & Dong-Yun Lee. (2023) Comparison of goserelin and leuprorelin for ovarian protection during chemotherapy in young patients with breast cancer. Breast Cancer Research and Treatment 198:2, pages 231-237.
Crossref
Marie-Madeleine Dolmans, Hugh S. Taylor, Kenny A. Rodriguez-Wallberg, Zeev Blumenfeld, Matteo Lambertini, Michael von Wolff & Jacques Donnez. (2020) Utility of gonadotropin-releasing hormone agonists for fertility preservation in women receiving chemotherapy: pros and cons. Fertility and Sterility 114:4, pages 725-738.
Crossref
Nigar Sofiyeva, Timo Siepmann, Kristian Barlinn, Emre Seli & Baris Ata. (2019) Gonadotropin-Releasing Hormone Analogs for Gonadal Protection During Gonadotoxic Chemotherapy: A Systematic Review and Meta-Analysis. Reproductive Sciences 26:7, pages 939-953.
Crossref
Zeev Blumenfeld. (2019) Fertility Preservation Using GnRH Agonists: Rationale, Possible Mechanisms, and Explanation of Controversy. Clinical Medicine Insights: Reproductive Health 13, pages 117955811987016.
Crossref
Wendy S. Vitek, Michelle Shayne, Kathleen Hoeger, Yu Han, Susan Messing & Chunkit Fung. (2014) Gonadotropin-releasing hormone agonists for the preservation of ovarian function among women with breast cancer who did not use tamoxifen after chemotherapy: a systematic review and meta-analysis. Fertility and Sterility 102:3, pages 808-815.e1.
Crossref
N.H. Turner, A. Partridge, G. Sanna, A. Di Leo & L. Biganzoli. (2013) Utility of gonadotropin-releasing hormone agonists for fertility preservation in young breast cancer patients: the benefit remains uncertain. Annals of Oncology 24:9, pages 2224-2235.
Crossref
Judy W. KingMelanie C. DaviesNicola RocheJacinta M. AbrahamAlison L. Jones. (2012) Fertility Preservation in Women Undergoing Treatment for Breast Cancer in the U.K.: A Questionnaire Study. The Oncologist 17:7, pages 910-916.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.